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Background
Allergenic tropomyosins are highly cross-reactive panaller-
gens found in various invertebrates. Sensitized patients can
develop allergic responses ranging from oral allergy syn-
drome to severe anaphylactic reactions after the ingestion
of tropomyosin-containing food. The usual routs of sensiti-
zation to tropomyosin include the airborne exposure to
various mites and cockroaches and the oral intake of crus-
taceans and mollusks. There were also reports of patients
with combined mite and seafood allergy who had experi-
enced a worsening of food allergy symptoms during house
dust mite-specific immunotherapy (HDM-SCIT). There-
fore, a possibility that mite tropomyosin present in allergen
extracts can cross-sensitize patients receiving HDM-SCIT
and thus induce food allergy is still investigated.Our aim
was to assess the occurrence and the clinical relevance of
tropomyosin sensitizations in HDM-SCIT-treated patients.
Methods
We studied 56 HDM-allergic patients treated with mite
extract-SCIT. All of them were initially screened for
sIgE to mite tropomyosin (rDer p 10) before and after
SCIT. In those with a positive result we also monitored
the dynamics of sIgE to both mite and shrimp (rPen a
1) tropomyosins at five time points: prior to treatment,
after initial therapy (~4 months), 1 and 2 years after
starting therapy, and after its completion. The levels of
sIgE were measured by the CAP-System FEIA.
Results
sIgE to tropomyosin was found in only 5 patients. Of
those, 3 expressed low and clinically irrelevant levels of
sIgE to Der p 10 during SCIT, while sIgE to Pen a 1
was not found at all. The remaining 2 patients expressed
sIgE to both tropomyosins. In the first, initial increase
and subsequent decrease resembled the dynamics of
IgE-antibodies usually seen in SCIT patients, while clini-
cally he had never expressed an allergic reaction to tro-
pomyosin-containing foods. In the other, who used to
develop oral allergy syndrome after consuming squids or
shrimps before SCIT, a decrease of sIgE to both tropo-
myosins resulted in the complete loss of his reactivity
toward seafood.
Conclusion
Induction of clinically relevant tropomyosin sensitiza-
tions is an unlikely consequence of HDM-SCIT.In some
cases of combined mite and seafood allergy the treat-
ment may even lead to the improvement of food allergy
symptoms.The levels of sIgE to tropomyosins might be
useful in monitoring, especially if their cutoff values pre-
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